Asthma

Commercial Insight: Asthma/COPD in Australia

Introduction

The Australian asthma/COPD market grew from $278m in 2006 to $333m in 2009. Its growth will slow considerably with the market projected to reach revenues of $354m in 2019. As new drugs launched will be me-too products or combinations of existing classes, Datamonitor assumes that these will be priced similarly to current brands in order to receive reimbursement, leading to a stabilizing market.

Scope mehr

Cough, Cold and Allergy (Hay Fever) Remedies - Guatemala

Cough, cold and allergy (hay fever) remedies helped drive consumer healthcare in 2009, accounting for 25% share of overall value sales. Consumption of these products increases during the rainy season (usually during the months of June through to October), which is when people are more prone to become ill with cough, colds and allergies. Combination products, which target more than one symptom, led the category, with value sales of GTQ44... mehr

Asthma Therapy Area Pipeline Report

Life Science Analytics', Asthma Therapy Area Pipeline Report contains detailed information on the asthma drug pipeline. This report provides insight into the pipeline status of asthma drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, ... mehr

Bronchitis Therapy Area Pipeline Report

Life Science Analytics', Bronchitis Therapy Area Pipeline Report contains detailed information on the bronchitis drug pipeline. This report provides insight into the pipeline status of bronchitis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug... mehr

Bronchospasm Therapy Area Pipeline Report

Life Science Analytics', Bronchospasm Therapy Area Pipeline Report contains detailed information on the bronchospasm drug pipeline. This report provides insight into the pipeline status of bronchospasm drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail o... mehr

Asthma - Drug Pipeline Analysis and Market Forecasts to 2016

Asthma - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, 'Asthma — Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global asthma market. The report identifies the key trends shaping and driving the global asthma market. The report also provides insight on the prevalent competiti... mehr

Pipeline Insight: Asthma/COPD - Simplified treatments to split the market

Introduction

With the introduction of once-daily combination products, the late-stage pipeline for asthma/COPD addresses the need for simplified treatment. The potential to improve patient compliance and therefore efficacy is highly anticipated. Late-stage pipeline launches are expected to inject nearly $10 billion into the asthma/COPD markets by 2018, boosting overall sales despite key patent expiries.

Scope
... mehr

Asthma and COPD Market Forecast

Introduction

Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.

Reaso... mehr

Commercial Insight: Asthma & COPD - On the verge of generic entry

Introduction

Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.

Scope... mehr

Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis

In the present era, use of tobacco, polluted environment, poverty and aging population have become a major threat; all these factors account for a major cause of deaths by COPD. Market for COPD medication is growing with increasing prevalence rate worldwide and it has become the fourth leading cause of death. The number of people with COPD varies throughout world. Cape Town has the highest prevalence of COPD, while Hanover has the lowes... mehr

Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers?

Introduction

The respiratory market will continue to grow with the same rate over the next few years, with a slight dip between 2012 and 2015 due to the patent expiries of leading products. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.

Scope

*Indication based forecasts fo... mehr

Respiratory and Pulmonary System Asthma

Life Science Analytics', 'Respiratory and Pulmonary System Asthma ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug p... mehr

Respiratory and Pulmonary System Bronchitis

Life Science Analytics', 'Respiratory and Pulmonary System Bronchitis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on dr... mehr

Respiratory and Pulmonary System Bronchospasm

Life Science Analytics', 'Respiratory and Pulmonary System Bronchospasm ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on ... mehr

Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease

Life Science Analytics', 'Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the ... mehr

Respiratory and Pulmonary System Cough

Life Science Analytics', 'Respiratory and Pulmonary System Cough ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pi... mehr

Respiratory and Pulmonary System Cystic Fibrosis

Life Science Analytics', 'Respiratory and Pulmonary System Cystic Fibrosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail ... mehr

Respiratory and Pulmonary System Nasal congestion

Life Science Analytics', 'Respiratory and Pulmonary System Nasal congestion ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail... mehr

Respiratory and Pulmonary System Respiratory Tract Infections

Life Science Analytics', 'Respiratory and Pulmonary System Respiratory Tract Infections ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with... mehr

Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma

Introduction

Asthma is managed using a step-wise approach, with bronchodilators to relieve symptoms of airflow limitation and controller medications to target underlying inflammation. Datamonitor's research shows that almost all patients (even those with mild intermittent asthma) receive some type of controller medication as their baseline treatment, which is in line with international management guidelines.

Scope<... mehr